Wave Life Sciences Ltd (NASDAQ: WVE) stock suffered a major decline of -10.1% on 3/27/25. The shares closed at $9.01. Moreover, trading volume in this decline was unusually high at 171% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -10.3% during the last week.
Current PriceTarget Research Rating
Wave Life Sciences has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Wave Life Sciences has a very low Appreciation Score of 1 but a very high Power Rating of 85, and the Negative Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment